Search Results for 'superficial femoral artery'
-
Cardiovascular
PQ Bypass Earns Breakthrough Designation for Fully Percutaneous Femoral-Popliteal Bypass Device
First device of its kind to treat extremely long, complex blockages in the superficial femoral artery, according to the company.Business Wire 09.03.20
-
TORUS 2 Clinical Study Underway for Peripheral Artery Disease Treatment
PQ Bypass' technology has been evaluated in the TORUS 1 study in Europe and is currently under evaluation in the DETOUR 2 IDE in the U.S. and Europe.Business Wire 12.16.19
-
Cardiovascular | Surgical
Medtronic's IN.PACT Admiral Drug-Coated Balloon Approved to Treat Long SFA Lesions
New indication expands DCB treatment for patients with superficial femoral artery lesions up to 360mm.GlobeNewswire 04.24.18
-
Cardiovascular
First Patient Treated in PQ Bypass DETOUR II Trial Evaluating New Treatment for Clogged Leg Arteries
PIVOTAL U.S. trial now underway for first-of-its-kind procedure in patients with severe peripheral artery disease.Business Wire 03.20.18
-
Cardiovascular
PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
Technologies expand treatment options for patients with extremely long superficial femoral artery blockages.Business Wire 03.24.17
-
PQ Bypass Announces Positive Results From DETOUR I Study
Trial evaluates percutaneous bypass treatment for PAD patients with complex superficial femoral artery occlusions.Business Wire 01.30.17
-
R&D & Design
FDA Approval for Gore’s Stent for Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies.W. L. Gore & Associates Inc. 08.02.16
-
Terumo Launches Self-Expanding Peripheral Stent to U.S. Market
Misago Rx received premarket approval in May.10.22.15
-
R&D & Design
FDA Approves Abbott’s Supera Peripheral Stent
The Supera peripheral stent system. Image courtesy of Abbott Vascular Inc. Abbott Vascular Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Supera peripheral stent system, designed for the treatment of people…04.08.14
-
R&D & Design
Angioslide Makes European Launch of New Device for Treatment of Entire Superficial Femoral Artery
Proteus device combines balloon angioplasty and embolic capture of particles.09.08.11
